Almac’s Clinical Technologies business unit is a leader in developing technologies to streamline site, patient, and drug supply management in the clinical trials industry, and the provider of the IXRS® interactive voice and web response system. Almac has formed an alliance with Greenphire to seamlessly automate patient payment administration and delivery through Almac's IXRS® technology platform.
Bio-Optronics, Inc., a leader in healthcare workflow software, has partnered with Greenphire to integrate Bio-Optronics’ Clinical Conductor™ Clinical Trial Management System with Greenphire’s ClinCard System. The joint technology platform enables clinical research sites to manage and automatically deliver all patient payments through their existing CTMS workflow.
Greenphire has partnered with the Biomedical Research Alliance of New York (BRANY) to provide Greenphire's clinical payment technologies to BRANY’s robust network of over 200 sites across the United States.
In October, 2011, Greenphire completed a Series A financing led by prominent New York-based venture capital firm, FirstMark Capital. FirstMark specializes primarily in quickly evolving industries including media, advertising, financial technology, and telecom. FirstMark Founder and Managing Director Gerald Poch currently serves as a member of Greenphire's Board of Directors.
Merge Healthcare is a leader in providing a wide range of clinical technologies, including ePRO, EDC, IVR/IWR, and others. Greenphire has formed a strategic partnership with the clinical trials division of Merge Healthcare to offer integrated functionality between Merge’s EDC technology and Greenphire’s eClinicalGPS site and vendor payment management technology.
Recognizing longstanding deficiencies in the traditional clinical trial process, San Francisco startup Mytrus Inc. has developed web-based solutions to enable clinical trials to be conducted remotely, including recruiting, retaining, and efficiently administering studies. Greenphire and Mytrus were able to jointly implement their technologies in Pfizer's recent REMOTE study, the first of it's type in the industry.
The Bancorp is a global issuing bank leader in the prepaid debit card market. The Bancorp currently serves as Greenphire's sponsor into the MasterCard network, enabling Greenphire's ClinCard System to adopt and seamlessly implement MasterCard's technologies to provide clinical patient stipend and reimbursement payments.
Citi is a global leader in international banking technologies, including prepaid and reloadable debit technologies. Greenphire and Citi currently partner to enable ClinCard System functionality throughout Europe, the Middle East, and Africa.
FIS Global is a world's largest provider dedicated to banking and payment technologies. As Greenphire's issuing processor, FIS ensures timely and accurate execution of transactions associated with Greenphire's technologies.
The MasterCard global network is comprised of over 32 million locations in over 200 countries. Greenphire's ClinCard System currently leverages MasterCard's debit card technology to provide the simplest, most efficient, and lowest cost patient payment platform in the clinical trials industry, with each ClinCard user receiving a MasterCard branded debit card with full access to the MasterCard financial network.
Wells Fargo currently serves as Greenphire's foreign exchange partner. As part of Wells Fargo's $12 billion of foreign exchange transactions each day, their robust technology enables Greenphire to deliver global clinical payments in local currency across over 200 countries.